secwatch.observer — SEC 8-K summary
======================================

Issuer:     Liquidia Corp (LQDA)
CIK:        0001819576
Form:       8-K
Filed at:   2024-05-31T23:59:59+00:00
Accession:  0001104659-24-067273
Event type: litigation
Sentiment:  negative
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

United Therapeutics sues Liquidia and ex-employee over YUTREPIA IP misappropriation
--------------------------------------------------------------------------------

- Complaint filed May 29, 2024 in Durham County, NC, against former employee and Liquidia subsidiary.
- Alleges breach of employment agreements and misappropriation of IP leading to YUTREPIA (treprostinil) inhalation powder.
- United Therapeutics seeks assignment of patents and declaratory relief that inventions belong to them.
- Liquidia intends to vigorously defend against the allegations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819576/000110465924067273/0001104659-24-067273-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819576/000110465924067273/tm2416192d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-067273

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer